Pregnancy and COVID-19: pharmacologic considerations
임신과 코로나19: 약리학적 고려사항
Review
[키워드] (Tocilizumab)
Administered
aerosolization
Algorithm
Analgesia
anticoagulation
Aspirin
benefit
caution
clinical trials
Comorbidity
Complication
contraindication
contraindications
convalescent plasma
coronavirus disease
Coronavirus disease 2019
Corticosteroid
Corticosteroids
Course
COVID-19
Critical
Critical illness
Dexamethasone
disease onset
disease severity
during pregnancy
Evidence
fetal
general anesthesia
gestation
Gynecology
hand
hypoxia
immunomodulator
immunomodulators
indicated
Inhaled
interferon
Intervention
lactating
lactation
Lopinavir
Lopinavir/ritonavir
low-dose
lung
Magnesium
magnesium sulfate
maturation
mechanically ventilated
monoclonal antibodies
monoclonal antibody
neuromuscular blockade
nitric oxide
Nitrous oxide
non-pregnant population
non-steroidal anti-inflammatory drug
Non-steroidal anti-inflammatory drugs
obstetrics
opioids
oxygen
Patient
patient-controlled analgesia
Personal protective equipment
Pregnancy
pregnancy complications
pregnant
pregnant patient
pregnant patients
Prevent
Prophylaxis
reduce
Remdesivir
remifentanil
renal
respiratory
respiratory depression
risk
Ritonavir
Seizure
shown
Society
Son
sulfate
supplemental oxygen
tacrolimus
Thromboprophylaxis
Tocilizumab
Treatment
Ultrasound
with COVID-19
[DOI] 10.1002/uog.23116 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/uog.23116 PMC 바로가기 [Article Type] Review